CLINICAL_TRIALS
trial_result
· 2023-12-11
Clinical Trial Update: Immune Intervention With Rituximab to Preserve Beta Cell Function in Early Onset Type 1 Diabetes [Phase 4]
Summary
Phase 4 trial update on rituximab to preserve beta cell function in early-onset type 1 diabetes has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Yang Tao | Conditions: Type 1 Diabetes | Phase 4 | Status: COMPLETED | Results posted: 2023-12-11